Cargando…
Immune Microenvironment Characteristics of Urachal Carcinoma and Its Implications for Prognosis and Immunotherapy
SIMPLE SUMMARY: Urachal carcinoma (UrC) is an exceedingly rare tumor and lacks effective treatment. Our study had some important suggestions for targeting programmed cell death-1 (PD-1)/programmed cell death-Ligand 1 (PD-L1) checkpoint in UrC. We fully analyzed the immune microenvironment including...
Autores principales: | Zhang, Xinke, Wang, Suijing, Nie, Run-Cong, Qu, Chunhua, Chen, Jierong, Yang, Yuanzhong, Cai, Muyan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8833550/ https://www.ncbi.nlm.nih.gov/pubmed/35158883 http://dx.doi.org/10.3390/cancers14030615 |
Ejemplares similares
-
Body mass index, as a novel predictor of hepatocellular carcinoma patients treated with Anti-PD-1 immunotherapy
por: Chen, Jierong, et al.
Publicado: (2022) -
Analysis of the Heterogeneity of the Tumor Microenvironment and the Prognosis and Immunotherapy Response of Different Immune Subtypes in Hepatocellular Carcinoma
por: Hu, Jian, et al.
Publicado: (2022) -
Progress and prospects of targeted therapy and immunotherapy for urachal carcinoma
por: Zheng, Yang, et al.
Publicado: (2023) -
Differentiated tumor immune microenvironment of Epstein–Barr virus-associated and negative gastric cancer: implication in prognosis and immunotherapy
por: Ma, Jing, et al.
Publicado: (2017) -
Immunosuppressive Tumor Microenvironment and Immunotherapy of Epstein–Barr Virus-Associated Malignancies
por: Zheng, Xueyi, et al.
Publicado: (2022)